Literature DB >> 25805947

Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.

Kathryn Fleming1, Andrew Ashcroft1, Christopher Alexakis1, Demitrios Tzias1, Christopher Groves1, Andrew Poullis1.   

Abstract

Five-amino salicylic acids are recommended for use in the management of inflammatory bowel disease, cardiac complications are a rare although recognised phenomenon. This report aims to highlight this serious but rare adverse reaction. We report here a case of a young man presenting with cardiogenic shock in the context of recent mesalazine treatment in severe ulcerative colitis.

Entities:  

Keywords:  Adverse reactions; Cardiomyopathy; Mesalazine; Ulcerative colitis

Mesh：

Substances：

Year:  2015        PMID： 25805947      PMCID： PMC4363770          DOI： 10.3748/wjg.v21.i11.3376

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  24 in total

1.  Cardiomyopathy and pericardial tamponade in ulcerative colitis.

Authors:  M Dubowitz; D A Gorard
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 2.566

2.  Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.

Authors:  Carlos Galvão Braga; Juliana Martins; Carina Arantes; Vítor Ramos; Catarina Vieira; Alberto Salgado; Sónia Magalhães; Adelino Correia
Journal:  Rev Port Cardiol       Date:  2013-08-30       Impact factor: 1.374

3.  Myocarditis by mesalazine with cardiac magnetic resonance imaging.

Authors:  Luis García-Ferrer; Jordi Estornell; Victor Palanca
Journal:  Eur Heart J       Date:  2009-01-24       Impact factor: 29.983

4.  Sudden death of a patient with Crohn's disease.

Authors:  M Hitosugi; O Kitamura; A Takatsu
Journal:  Nihon Hoigaku Zasshi       Date:  1998-06

5.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

6.  Fatal giant cell myocarditis after colectomy for ulcerative colitis.

Authors:  J McKeon; B Haagsma; J H Bett; C M Boyle
Journal:  Am Heart J       Date:  1986-06       Impact factor: 4.749

7.  Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis.

Authors:  A Ariza; M D López; J L Mate; A Curós; M Villagrasa; J J Navas-Palacios
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

8.  Myocarditis in children with inflammatory bowel disease.

Authors:  C Frid; B Bjarke; M Eriksson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 Nov-Dec       Impact factor: 2.839

9.  Mesalamine-induced myocarditis.

Authors:  Olivier Merceron; Clement Bailly; Antoine Khalil; Florence Pontnau; Nadjib Hammoudi; Richard Dorent; Pierre-Louis Michel
Journal:  Cardiol Res Pract       Date:  2010-09-13       Impact factor: 1.866

Review 10.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors:  L Sutherland; J K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  2 in total

Review 1.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

2.  Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature.

Authors:  Giacomo Caio; Lisa Lungaro; Fabio Caputo; Maria Muccinelli; Maria Caterina Marcello; Eleonora Zoli; Umberto Volta; Roberto De Giorgio; Giorgio Zoli
Journal:  BMJ Open Gastroenterol       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.